B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PDCD4

MOLECULAR TARGET

programmed cell death 4

UniProt: Q53EL6NCBI Gene: 272503 compounds

PDCD4 (programmed cell death 4) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PDCD4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1sirolimus4.82123
2Sirolimus0.691
3Tubercidin0.691

About PDCD4 as a Drug Target

PDCD4 (programmed cell death 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented PDCD4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PDCD4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.